The frequency of occurrence of anti-cardiac receptor autoantibodies and their correlation with clinical manifestation in patients with hypertrophic cardiomyopathy

Autoimmunity

Volumn 29, Issue 4, 1999, Pages 291-297

  Peukert, Simone ^a   Fu, Michael L X ^c   Eftekhari, Pierre ^c   Poepping, Imke ^a   Voss, Andreas ^b   Thalhammer, Christoph ^a   Hempel, Albrecht ^a   Menz, Marianne ^a   Dietz, Rainer ^a   Osterziel, Karl Josef ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c NONE

Author keywords

Autoantibody; Clinical manifestation; Hypertrophic cardiomyopathy

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; MUSCARINIC M2 RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; QT INTERVAL;

EID: 0032940110     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908994749     Document Type: Article

References (36)

1. Maron, B.J. and Epstein, S.E. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am. J. Cardiol. 1979; 43: 1242-1244.
2. Jarcho, J.A., McKenna, W.J., Pare, J.A.P. et al. Mapping of a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N. Engl. J. Med. 1989; 321: 1372-1378.
3. Watkins, H., MacRae, C., Thierfelder, L. et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat. Genet 1993; 3: 333-337.
4. Thierfelder, L., MacRae, C., Watkins, H. et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc. Nat. Acad. Sci. USA 1993; 90: 6270-6274.
5. Carrier, L., Hengstenberg, C., Beckmann, J.S. et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat. Genet. 1993; 4: 311-313.
6. Thierfelder, L., Watkins, H., MacRae, C. et al. Alpha-tropomyosin and cardiac troponin T-mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701-712.
7. Poetter, K., Jiang, H., Hassanzadeh, S. et al. Mutations in either the essential or regulatory light chains of myosin are associated with myopathy in human heart and skeletal muscle. Nat. Genet. 1996; 13: 63-68.
8. Hengstenberg, C. and Schwartz, K. Molecular Genetics of familial hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 1994; 26: 3-10.
9. Watkins, H., Conner, D., Thierfelder, L. et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat. Genet. 1995; 11: 434-437.
10. Kimura, A., Harada, H., Park, J.E. et al. Mutation in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 1997; 16: 379-382
11. Boudonas, G., Boura, P., Lefkos, N., Zacharioydaki, E., and Efthymiadis, A. A possible role for AAB in left ventricular hypertrophy. Cardiology 1994; 84: 278-283.
12. Autore, C., Fiorito, S., Pelliccia, A. et al. Antimitochondrial autoantibodies in myocardial hypertrophy: comparison between hypertrophic cardiomyopathy, hypertensive heart disease, and athlete's heart. Am. Heart. J. 1988; 116: 496-500.
13. Fu, M.L.X., Hoebeke, J., Matsui, S. et al. Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin. Immunol. Immunopath. 1994; 72: 15-20.
14. Matsui, S., Fu, M.L.X., Shimizu, M. et al. Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. Autoimmunity 1995; 21: 85-88.
15. Caforio, A.L.P., Grazzini, M., Mann, J.M. et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilative cardiomyopathy. Circulation 1992; 85: 1734-1742.
16. Latif, N., Baker, C.S., Dunn, M.J., Brady, P. and Yacoub, M.H. Frequency and specificity of antiheart antibodies in patients with dilative cardiomyopathy detected using SDS-PAGE and Western blotting. J. Am. Coll. Cardiol. 1993; 22: 1378-1384.
17. Dörffel, W.V., Felix, S.F., Wallukat, G. et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997; 95: 1994-1997.
18. Furuta, H., Guo, D.F. and Inagami, T. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem. Biophys. Res. Comm. 1992; 183: 8-13.
19. Bruno, J.F., Whittaker, J., Song, J. et al. Molecular cloning and sequencing of a cDNA encoding a human alpha 1a adrenergic receptor. Biochem. Biophys. Res. Comm. 1991; 179: 1485-1490.
20. 1-adrenergic receptor. Proc. Nat. Acad. Sci. 1987; 84: 7920-7924.
21. 2-receptor. Science 1987; 230: 600-605.
22. Fu, M.L.X., Magnuson, Y., Bergh, C. et al. Localization of functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilative cardiomyopathy. J. Clin. Invest. 1993; 91: 1964-1968.
23. Voss, A., Kurths, J., Kleiner, H.J., Witt, A. and Wessel, N. Improved analysis of heart rate variability by methods of non-linear dynamics. J. Electrocardiol. 1995; 28 (suppl.): 81-88.
24. Voss, A., Kurths, J., Kleiner, H.J. et al. The application of methods of non-linear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. Cardiovas. Res. 1996; 31: 419-433.
25. Herskowitz, A., Neumann, D.A. and Ansari, A.A. Concepts of autoimmunity applied to idiopathic dilated cardiomyoparty. J. Am. Coll. Cardiol. 1993; 22: 1385-1388.
26. Fauci, A.S. Activation and regulation of human immune responses: implications in normal and disease states. Ann. Int. Med. 1983; 99: 61-75.
27. Fallen, E.L., Kamath, M.V. and Ghista, D.N. Power spectrum of heart rate variability: a non-invasive test of integrated neurocardiac function. Clin. Invest. Med. 1988; 213: 331-340.
28. Akselrod, S., Gordon, D., Ubel, F.A., Shannon, D.C., Barger, A.C. and Cohen, R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-222.
29. Voss, A. and Esperer, H.D. Herzfrequenzvariabilität. Definition, Analyse und klinische Bedeutung. Herz & Rhythmus 1994; 6: 1-7 (part 1); and 1995; 7: 3-8 (part 2).
30. Voss, A. and Esperer, H.D. Herzfrequenzvariabilität. Definition, Analyse und klinische Bedeutung. Herz & Rhythmus 1994; 6: 1-7 (part 1); and 1995; 7: 3-8 (part 2).
31. c-interval at discharge after acute myocardial infarction: a multicenter study of 865 patients. Am. Heart. J. 1984; 108: 395-400.
32. c prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991; 83: 1888-1894.
33. Kleiger, R.E., Stein, P.K., Bosner, M.S. and Rottman, J.N. Time domain measurements of heart rate variability. Cardiol. Clin. 1992; 10: 487-498.
34. Kleiger, R.E., Miller, J.P. Bigger, J.T. et al. Decreased heart beat variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 1987; 59: 256-262.
35. Maron, B.J., Bonow, R.O., Cannon, R.O., Leon, M.B. and Epstein, S.E. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (1. part). N. Engl. J. Med. 1987; 316: 780-789.
36. Maron, B.J., Wolfson, J.K., Epstein, S.E. and Roberts, W.C. Intermural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 1986; 8: 545-550.